Department of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas 50009, Lithuania.
Department of Surgery, Georgetown University Hospital, Reservoir 3800, Washington, DC 20007, United States.
World J Gastroenterol. 2017 Nov 21;23(43):7785-7790. doi: 10.3748/wjg.v23.i43.7785.
To explore the outcomes and the appropriate treatment for patients with moderately severe acute pancreatitis (AP).
Statistical analysis was performed on data from the prospectively collected database of 103 AP patients admitted to the Department of Surgery, Hospital of Lithuanian University of Health Sciences in 2008-2013. All patients were confirmed to have the diagnosis of AP during the first 24 h following admission. The severity of pancreatitis was assessed by MODS and APACHE II scale. Clinical course was re-evaluated after 24, 48 and 72 h. All patients were categorized into 3 groups based on Atlanta 2012 classification: Mild, moderately severe, and severe. Outcomes and management in moderately severe group were also compared to mild and severe cases according to Atlanta 1992 and 2012 classification.
Fifty-three-point four percent of patients had edematous while 46.6 % were diagnosed with necrotic AP. The most common cause of AP was alcohol (42.7%) followed by alimentary (26.2%), biliary (26.2%) and idiopathic (4.9%). Under Atlanta 1992 classification 56 (54.4%) cases were classified as "mild" and 47 (45.6%) as "severe". Using the revised classification (Atlanta 2012), the patient stratification was different: 49 (47.6%) mild, 27 (26.2%) moderately severe and 27 (26.2%) severe AP cases. The two severe groups (Atlanta 1992 and Revised Atlanta 2012) did not show statistically significant differences in clinical parameters, including ICU stay, need for interventional treatment, infected pancreatic necrosis or mortality rates. The moderately severe group of 27 patients (according to Atlanta 2012) had significantly better outcomes when compared to those 47 patients classified as severe form of AP (according to Atlanta 1992) with lower incidence of necrosis and sepsis, lower APACHE II ( = 0.002) and MODS ( = 0.001) scores, shorter ICU stay, decreased need for interventional and surgical treatment.
Study shows that Atlanta 2012 criteria are more accurate, reduce unnecessary treatments for patients with mild and moderate severe pancreatitis, potentially resulting in health costs savings.
探讨中度重症急性胰腺炎(AP)患者的治疗效果和预后。
对 2008 年至 2013 年期间在立陶宛健康科学大学医院外科住院的 103 例 AP 患者的前瞻性数据库资料进行统计学分析。所有患者在入院后 24 小时内均被确诊为 AP。通过 MODS 和 APACHE II 评分评估胰腺炎的严重程度。在 24、48 和 72 小时后对临床病程进行重新评估。根据亚特兰大 2012 分类,所有患者均分为三组:轻症、中度重症和重症。根据亚特兰大 1992 年和 2012 年分类,还将中度重症组的治疗方法与轻症和重症病例进行了比较。
53.4%的患者为水肿性胰腺炎,46.6%的患者为坏死性胰腺炎。AP 的最常见病因是酒精(42.7%),其次是饮食(26.2%)、胆源性(26.2%)和特发性(4.9%)。根据亚特兰大 1992 年分类,56 例(54.4%)为“轻症”,47 例(45.6%)为“重症”。采用修订后的分类(亚特兰大 2012 年),患者分层不同:49 例(47.6%)为轻症,27 例(26.2%)为中度重症,27 例(26.2%)为重症 AP。两个重症组(亚特兰大 1992 年和修订后的亚特兰大 2012 年)在 ICU 住院时间、介入治疗需求、感染性胰腺坏死或死亡率等临床参数方面无统计学差异。与根据亚特兰大 1992 年分类的 47 例重症患者相比,根据亚特兰大 2012 年分类的 27 例中度重症患者的预后明显更好,坏死和脓毒症的发生率较低,APACHE II 评分(=0.002)和 MODS 评分(=0.001)较低,ICU 住院时间较短,介入和手术治疗的需求减少。
研究表明,亚特兰大 2012 标准更为准确,减少了对轻症和中度重症胰腺炎患者的不必要治疗,可能会降低医疗费用。